PSEUDOMYXOMA PERITONEI

Clinical trials for PSEUDOMYXOMA PERITONEI explained in plain language.

Never miss a new study

Get alerted when new PSEUDOMYXOMA PERITONEI trials appear

Sign up with your email to follow new studies for PSEUDOMYXOMA PERITONEI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

Immunotherapy duo takes on 50+ rare cancers in major trial

Disease control Ongoing

This phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…

Matched conditions: PSEUDOMYXOMA PERITONEI

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

PSEUDOMYXOMA PERITONEI

Get alerted when new PSEUDOMYXOMA PERITONEI trials appear

Immunotherapy duo takes on 50+ rare cancers in major trial